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The UK’s official drug policy advisers conclude that the ageing profile of heroin users with increasingly
complex health needs has contributed to recent increases in drug-related deaths, and that to hold down the
increases government must maintain investment in substitute prescribing programmes like methadone
maintenance.
SUMMARY The UK’s Advisory Council on the Misuse of Drugs (ACMD) was established under the Misuse of
Drugs Act 1971 to advise the government on the control of dangerous or otherwise harmful drugs,
including classification and scheduling under the Misuse of Drugs Act 1971 and its regulations. In March
2016 the Council agreed to initiate an investigation into the recent increases in drug-related deaths in the
UK. In December 2016 the featured report was sent to government in the person of the Home Secretary
with a letter co-signed by the chair of the Advisory Council on the Misuse of Drugs and the co-chairs of the
working group of the Council which produced the report. The first part of this account consists of extracts
from the letter and the second part extracts from the report’s own summary.
Letter to Home Secretary
In recent years, there have been substantial increases in the number of people dying in the UK where illicit
drugs are reported to be involved in their death. The largest increase has been in deaths related to the
misuse of opioid substances; 2,677 opioid-related deaths were registered in the UK in 2015. The ACMD
therefore set up a dedicated working group to examine how to reduce drug-related deaths, with a focus on
opioid-related deaths.
Through our brief review of the potential causes of recent trends in opioid-related death, the ACMD can
assert with a good degree of confidence that the ageing profile of heroin users with increasingly complex
health needs (including long-term conditions and poly-substance use), social care needs and continuing
multiple risk behaviours has contributed to recent increases in drug-related deaths.
Other possible causes of recent increases include greater availability of heroin at street level, deepening of
socio-economic deprivation since the financial crisis of 2008, changes to drug treatment and commissioning
practices, and lack of access to mainstream mental and physical health services for this ageing cohort.
The ACMD welcomes the considerable expansion in the use of OST (opioid substitute treatment) [based on
the long-term prescribing of drugs with opiate-type effects which ‘substitute’ for the drugs the patient is
dependent on but which are less damaging, primarily in the UK methadone but also buprenorphine and
other opioids] in the UK since the mid-1990s. The ACMD would like to re-iterate the evidence that being in
OST protects heroin users from overdose, and increasing coverage of OST has had a substantial effect in
limiting the increase in drug-related deaths that would otherwise have occurred. The most important
recommendation in this report is that government ensures that investment in OST of optimal dosage and
duration is, at least, maintained. Access to allied healthcare and other services to treat comorbid, chronic
physical and mental health issues, and to promote recovery from problematic drug use will also be
important in reducing premature deaths.
Report summary
The Advisory Council on the Misuse of Drugs (ACMD) has a statutory duty under the Misuse of Drugs Act
1971 to advise ministers on measures that may be taken to reduce the harms associated with illicit drugs.
Death is the most serious harm related to drug use. Since 2012, there have been substantial increases in
the numbers of people dying in the UK where illicit drugs are reported to be involved in their death. Table 1
displays the numbers of deaths that have been registered as drug misuse deaths and as opioid-related
deaths in the most recent year for which data is available in each country of the UK. It also shows the
percentage change in deaths recorded as opioid-related between 2012 and 2015.
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Table 1: Drug misuse and opioid-related deaths in the UK (by year of
registrations)
Country Drug misuse
deaths (2015)
Opioid-related
deaths (2015)
% increase in opioid-
related deaths 2012–2015
England 2,300 1,842 58%
Wales 168 141 23%
Scotland 706 606 21%
Northern
Ireland
114 88 47%
As shown in Table 1, a very large number of drug misuse deaths are related to opioids, and this
number has grown substantially in recent years. Indeed, figures from the Office for National
Statistics (ONS) for 2015 registrations suggest that opioid-related deaths ... accounted for a larger
number of fatalities than traffic accidents. People who use opioids are also highly vulnerable to other
causes of death; 43% of deaths recorded among a large cohort of opioid users in England were due
to fatal overdose, with the majority dying of other causes.
[T]his report is based on analysis of published research, on research undertaken by members of the
above-mentioned working group and consultation with stakeholders in the field. The main
conclusions of the report are as follows.
 That the UK has high-quality systems for the recording of opioid-related deaths, but that more
could be done to improve national information, especially on toxicology and prescribing, as well as
on the contribution of opioid use to levels of mortality from other causes.
 That a probable cause of the recent increases in drug-related deaths is the existence of a
prematurely ageing cohort of people who have been using heroin since the 1980s and 1990s.
 The vulnerability of these and other people who use heroin is likely to have been reduced by a
reduction in the availability of heroin at street level that occurred in the UK in 2010 to 2012. Recent
increases may represent a return to the underlying, increasing trend as heroin availability
subsequently increased.
 Other contributory causes of recent increases in deaths include multiple health risks (including
poly-substance use and chronic use of alcohol and tobacco) among an ageing cohort of heroin or
opioid users, deepening of socio-economic deprivation since the financial crisis of 2008, and changes
to drug treatment and commissioning practices.
 There are a number of evidence-based approaches that can be used to reduce the risk of death
among people who use opioids. The strongest evidence supports the provision of opioid substitution
treatment (OST) of optimal quality, dosage and duration.
 Other substance misuse treatment options could be further developed in order to reduce the risk
of death including broader provision of naloxone, heroin-assisted treatment for those for whom
other forms of OST are not effective, medically-supervised drug consumption clinics, treatment for
alcohol problems, and assertive outreach to engage heroin users who are not in treatment into OST
(especially for those who are homeless and/or have mental health problems).
 Improve[d] access for heroin users to treatment for mental health problems, smoking cessation
and tobacco harm reduction, HIV/hepatitis B/hepatitis C prevention and treatment, physical
healthcare treatment for long-term conditions such as coronary and pulmonary heart disease, and
other services (such as housing and employment services) which support wider recovery outcomes
could reduce vulnerability to [drug-related deaths].
 The report makes a number of recommendations for the reduction of opioid-related deaths; most
importantly that investment in evidence-based OST be maintained. It is estimated that OST was
preventing approximately 880 deaths per year in England in 2008 to 2011. Without the expansion
of OST that occurred in the 2000s, it is likely that opioid-related deaths would be even higher than
they currently are. These services are currently under threat from reductions in local and national
funding, especially in England.
 The age profile of opioid-related deaths ... suggests that relatively few young people are initiating
problematic opioid use. Numbers of opioid-related deaths among people under 30 have fallen
substantially since the early 2000s. This suggests that the UK is likely to see a long-term reduction
in opioid-related deaths, as long as there is no new wave of initiation into problematic opioid use
(eg, larger increases in the misuse of heroin, fentanyl and/or oxycodone), as was seen with heroin
in the 1980s and 1990s.
 However, in the short to medium term, we are likely to see an increasing number of deaths among
a shrinking population of prematurely ageing, increasingly vulnerable heroin or opioid users. Deaths
among this cohort have been reduced and limited by previous government interventions, including
those implemented after the ACMD’s report in 2000. ACMD calls on the government to renew and
extend efforts to prevent these deaths.
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 COMMENTARY An Effectiveness Bank hot topic has addressed why the fall in
UK drug misuse deaths in 2009 to 2012 so decisively reversed in the following years. The
featured report is commented on in the hot topic, which also offers a comprehensive account
of the statistics, research, the policy background and the debates on drug misuse deaths (and
specifically opioid-related deaths) in the UK.
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